Europe — EMA

Ondansetron Kalceks

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for intramuscular, intravenous use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for intramuscular, intravenous use. It treats and prevents nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery in adults and children. GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Ondansetron used for?

Ondansetron is a selective serotonin 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of CINV episodes in patients receiving high‑emetogenic chemotherapy. - Post‑operative Post‑POD S … .... - .... … .... ... … … ...

What are the side effects of Ondansetron?

… ... ...

What precautions apply to Ondansetron?

… …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →